zeteletinib   Click here for help

GtoPdb Ligand ID: 11416

Synonyms: Example 3 [WO2018060714A1]
Compound class: Synthetic organic
Comment: This entry was generated from the chemical structure for the INN zeteletinib, which resolved via PubChem and SureChEMBL to Daiichi Sankyo patent WO2018060714A1 [1]. The compounds in this patent are claimed as RET kinase inhibitors, principally for the treatment of proliferative diseases. The zeteletinib structure is claimed as Example 3. In the absence of formal name>structure disclosure we have been unable to determine the clinical development stage of this compound.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 99.37
Molecular weight 500.17
XLogP 4.39
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1cc2cc(cnc2cc1OC)c1ccc(cn1)CC(=O)Nc1onc(c1)C(C(F)(F)F)(C)C
Isomeric SMILES COc1cc2cc(cnc2cc1OC)c1ccc(cn1)CC(=O)Nc1onc(c1)C(C(F)(F)F)(C)C
InChI InChI=1S/C25H23F3N4O4/c1-24(2,25(26,27)28)21-11-23(36-32-21)31-22(33)7-14-5-6-17(29-12-14)16-8-15-9-19(34-3)20(35-4)10-18(15)30-13-16/h5-6,8-13H,7H2,1-4H3,(H,31,33)
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
International Nonproprietary Names Click here for help
INN number INN
11523 zeteletinib
Synonyms Click here for help
Example 3 [WO2018060714A1]
Database Links Click here for help
CAS Registry No. 2216753-97-6 (source: WHO INN record)
GtoPdb PubChem SID 440816785
PubChem CID 134391533
Search Google for chemical match using the InChIKey KOLQINCWMXQEOF-UHFFFAOYSA-N
Search Google for chemicals with the same backbone KOLQINCWMXQEOF
Search PubMed clinical trials zeteletinib
Search PubMed titles zeteletinib
Search PubMed titles/abstracts zeteletinib
Search UniChem for chemical match using the InChIKey KOLQINCWMXQEOF-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone KOLQINCWMXQEOF